Clinical Trials · NCT03560960
Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease
- Phase
- EARLY_Phase 1
- Recruitment status
- Active Not Recruiting
- Sponsor
- Boston University
- Enrollment
- 57
- Start date
- Feb 2020
- Locations
- 3 sites, United States
- Primary endpoint
- Plasma Aβ 1-40 levels